Results by group103

Each measurement the trial posted, group by group, in the words and numbers it posted.

41 to 60 of 103

Outcome	Group	Category	Value	Spread	Units
Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30	Placebo: Part 2	EOCons: GHS:GHS	37.1	Standard Deviation 24.54	scores on a scale
Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30	Midostaurin: Part 2	EOCont: GHS:GHS	28.3	Standard Deviation 22.52	scores on a scale
Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30	Placebo: Part 2	EOCont: GHS:GHS	27.8	Standard Deviation 10.09	scores on a scale
Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30	Midostaurin: Part 2	EOT:GHS:GHS	25.5	Standard Deviation 21.94	scores on a scale
Change From Baseline in Quality of Life (QoL) Per European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30	Placebo: Part 2	EOT:GHS:GHS	28.8	Standard Deviation 23.33	scores on a scale
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOI: Very much improved	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOI: Very much improved	0		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOI: Much improved	2		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOI: Much improved	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOI: Minimally improved	3		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOI: Minimally improved	0		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOI: No change	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOI: No change	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOI: Minimally worse	0		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOI: Minimally worse	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOCons: Very much improved	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOCons: Very much improved	1		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOCons: Much improved	2		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Placebo: Part 2	EOCons: Much improved	3		Participants
Quality of Life (QoL) Per Patient Global Impression of Change (PGIC)	Midostaurin: Part 2	EOCons: Minimally improved	2		Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03280030/results?page=3

API reference For AI assistants